(Q43006060)

English

EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries

scientific article published on October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

circulatory system

1 reference

based on heuristic

inferred from title

EUROASPIRE Study Group

8

object named as

EUROASPIRE Study Group

0 references

3

object named as

Guy De Backer

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kornelia Kotseva

object named as

Kornelia Kotseva

1

0 references

Dirk De Bacquer

object named as

Dirk De Bacquer

4

0 references

author name string

David Wood

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kalevi Pyörälä

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Zeljko Reiner

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Ulrich Keil

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

EUROASPIRE Study Group

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

European Journal of Cardiovascular Prevention and Rehabilitation

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

530-540

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice ...

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Smoking cessation: evidence based recommendations for the healthcare system

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Effectiveness of smoking cessation therapies: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

The evidence for dietary prevention and treatment of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Adherence to Mediterranean diet and health status: meta-analysis

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Prevention of coronary heart disease by diet and lifestyle: evidence from prospective cross-cultural, cohort, and intervention studies

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Serum cholesterol during 27 years: assessment of systematic error and affecting factors and their role in interpreting population trends.

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Assessment of the white-coat effect.

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Hypertension treatment and control in five European countries, Canada, and the United States

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Hypertension management and control among English adults aged 65 years and older in 2000 and 2001.

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised con

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283383F30

21 January 2018

Identifiers

10.1097/HJR.0B013E3283383F30

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43006060&oldid=2019487433"